2014 Young Investigator Symposium

Eight Young Investigators to Present Diverse Research

Distinction Award for Clinical Research
Andrew Laccetti, MD
Internal Medicine Resident, University of Texas Southwestern Medical Center
Prior Cancer Exclusion Widely and Unnecessarily Restricts Enrollment in Lung Cancer Clinical Trials

Distinction Award for Translational Research
Dustin A. Deming, MD
Assistant Professor of Medicine, University of Wisconsin
Dual PI3K/mTOR Inhibition for the Treatment of PIK3CA and APC Mutated Colorectal Cancers

Yanis Boumber, MD, PhD
Assistant Professor of Medicine, Fox Chase Cancer Center
Striking Preclinical Efficacy of STA-12-8666, an HSP90 Inhibitor-Targeted SN-38 Conjugate, in Small-Cell Lung Cancer

Wei Ding, MBBS, PhD
Assistant Professor of Medicine, Mayo Clinic Rochester
The AKT Inhibitor MK-2206 in Combination with Rituximab and Bendamustine Demonstrates Promising Efficacy in Relapsed or Refractory Chronic Lymphocytic Leukemia: Updated Results from an Early Phase Study (NCCTG N1087)

P. Brent Ferrell, Jr., MD
Clinical Fellow, Vanderbilt-Ingram Cancer Center
Systematic Mass Cytometry Phenotyping of Early Therapy Response in Acute Myeloid Leukemia

Annie Im, MD
Assistant Professor of Medicine, University of Pittsburgh
Epigenetic Priming Using Decitabine followed by Cytarabine as an Induction Regimen in Older Patients with Newly Diagnosed Acute Myeloid Leukemia

Athena Kritharis, MD
Hematology/Oncology Fellow, Tufts Medical Center
A Comparative Oncology Study of Canine and Human Genomics and Proteomics in Peripheral T-Cell Lymphoma: Examination of Shared Oncogenic Signaling for Biomarker and Therapeutic Target Discovery

Conor E. Steuer, MD
Chief Fellow, Winship Cancer Center of Emory University
A Comparison of the Oncogenic Drivers and Outcomes of Lung Cancers by Race/Ethnicity: A Report of the Lung Cancer Mutation Consortium

Return to Home | Return to Young Investigator Home Page